ENVB
Enveric Biosciences, Inc.
1W: -2.0%
1M: -10.4%
3M: -62.4%
YTD: -46.3%
1Y: -90.6%
3Y: -99.4%
5Y: -100.0%
$1.97
+0.02 (+1.03%)
After Hours: $1.99 (+0.02, +1.02%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.2M
52W Range1.82-21.24
Volume20,592
Avg Volume377,989
Beta0.30
Dividend—
Analyst Ratings
Company Info
CEOJoseph Edward Tucker
Employees5
SectorHealthcare
IndustryBiotechnology
IPO Date2015-05-04
Websiteenveric.com
4851 Tamiami Trail North
Naples, FL 34103
US
Naples, FL 34103
US
239 302 1707
About Enveric Biosciences, Inc.
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Latest News
Enveric rises as Gilgamesh drops patent petition
Enveric Biosciences Announces Withdrawal of Petition Against Its Patent
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Coveney Kevin Michae | A-Award | 74,150 | — | 2025-05-08 |
| Facchini Peter J. | A-Award | 24,717 | — | 2025-05-08 |
| Tucker Joseph Edward | A-Award | 98,866 | — | 2025-05-08 |
| DeWitt Sheila | A-Award | 27,845 | — | 2024-10-09 |
| Kegler George A. | A-Award | 47,733 | — | 2024-10-09 |